United States· US:25021-118_da170a9c-def7-432b-8999-701e7b878fe8
Cefuroxime sodium
A medicinal product containing cefuroxime sodium, registered in United States by Sagent Pharmaceuticals.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CEFUROXIME SODIUM
- Manufacturer
- Sagent Pharmaceuticals
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1125021-118-10
- ndc11250211181025 VIAL in 1 CARTON (25021-118-10) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Cefuroxime sodium in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandCefuroxime 750 mg Powder for Injection/InfusionFlynn Pharma Limited
- PolandAprokamLaboratoires Thea
- United KingdomAprokam 50mg powder for solution for injection vialsThea Pharmaceuticals Ltd
- SpainCEFUROXIMA ALTER 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Alter S.A.
- FinlandAprokamLaboratoires Thea
- SwitzerlandAprokam, poudre pour solution injectableTHEA Pharma S.A.
- CzechiaAPROKAMLaboratoires Thea, Clermont-Ferrand
- GermanyAprokamLaboratoires Thea
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Aprokam, Cefuroxim Aptapharma
- Belgium · Aprokam, Cefuroxim Fresenius Kabi
- Bulgaria · Аксетин, Аксеф
- Cyprus · Axetine, Cefurax
- Czechia · Aprokam, Axetine
- Germany · Aprokam, Cefurax
- Denmark · Aprokam, Cefuroxim B. Braun
- Estonia · Axetine, Cefuroxime Mip
- Spain · Cefuroxima Alter, Cefuroxima Cinfa
- Finland · Aprokam, Cefirion
- France · Aprokam, Cefuroxime Arrow
- United Kingdom (Northern Ireland) · Aprokam, Cefuroxime
- Greece · Anaptivan, Cefur
- Croatia · Axetine, Beloxim
- Hungary · Cefuroxim Kabi, Cefuroxime Aptapharma
- Ireland · Aprok, Ceftal
- Iceland · Aprokam, Cefuroxim Fresenius Kabi
- Italy · Aprokam, Cefuroxima K24 Pharmaceuticals
- Lithuania · Axetine, Cefuroxime Mip
- Luxembourg · Aprokam, Cefuroxim Fresenius
- Latvia · Axetine, Cefuroxime Bcpp
- Malta · Axetine, Cefuroxime Axetil Ccav
- Netherlands · Aprokam, Cefuroxim Fresenius Kabi
- Norway · Aprokam, Cefuroxim B. Braun
- Poland · Aprokam, Biofuroksym
- Portugal · Antibioxime, Aprokam
- Romania · Aprokam, Axetine
- Sweden · Aprokam, Cefuroxim Mip
- Slovenia · Aprokam, Cefuroksim Aptapharma
- Slovakia · Aprokam, Axetine
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e656bb96-8ef3-4ecd-ac69-3b5bd1c921fe GET /v1/drugs/e656bb96-8ef3-4ecd-ac69-3b5bd1c921fe?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAMUSCULAR; INTRAVENOUS",
"source": "ndc",
"strength": "750",
"substance": "CEFUROXIME SODIUM",
"productndc": "25021-118",
"dosage_form": "INJECTION, POWDER, FOR SOLUTION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA064125",
"marketing_category": "ANDA"
}See everything about cefuroxime sodium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.